INDIA AT 100 KILOS
TAKING STOCK OF INDIA’S GROWING ON OBESITY PROBLEM
Read India’s Obesity Signals
Before Your Next Move
If your category touches weight, food,
fitness, metabolic health, diabetes, nutrition, obesity treatment.
KOBI helps you read India’s obesity signals
before you make your next move.
What You'll Learn
✔
Why obesity is much more than excess body weight
✔ Why metabolic risk often appears before visible obesity
✔ The gap between public perception and clinical reality
✔ How families influence long-term metabolic health
✔ Why behaviour not just awareness determines outcomes
✔ The future of GLP-1 therapies in India
✔ How obesity impacts productivity, insurance, diagnostics, and healthcare
✔ Why businesses need obesity intelligence not just obesity awareness
✔ How early recognition can transform prevention and care
About the Book
This publication brings together:
Research from leading Indian and global health organizations
Expert insights from obesity specialists
KOBI Signals based on urban consumer, doctor, fitness
professional, and GLP-1 awareness studies
Business implications for healthcare, pharma, diagnostics,
nutrition, wellness, insurance, and workplace health.
India’s Obesity Story Is Still Being Written.
The question is no longer whether obesity is changing India.
The question is whether your organization is
ready to understand what comes next.
Download your complimentary copy of India
Obesity Intelligence and start reading India’s
obesity signals before your next business,
healthcare, or policy decision.
INDIA AT 100 KILOS
TAKING STOCK OF INDIA’S GROWING ON OBESITY PROBLEM
Read India’s Obesity Signals
Before Your Next Move
If your category touches weight, food,
fitness, metabolic health, diabetes, nutrition, obesity treatment.
KOBI helps you read India’s obesity signals
before you make your next move.
What You'll Learn
-
Why obesity is much more than excess body weight
-
Why metabolic risk often appears before visible obesity
-
The gap between public perception and clinical reality
-
How families influence long-term metabolic health
-
Why behaviour not just awareness determines outcomes
-
The future of GLP-1 therapies in India
-
How obesity impacts productivity, insurance, diagnostics, and healthcare
-
Why businesses need obesity intelligence not just obesity awareness
-
How early recognition can transform prevention and care
About the Book
This publication brings together:
Research from leading Indian and global health organizations
Expert insights from obesity specialists
KOBI Signals based on urban consumer, doctor, fitness professional, and GLP-1 awareness studies
Business implications for healthcare, pharma, diagnostics, nutrition, wellness, insurance, and workplace health.
India’s Obesity Story Is Still Being Written.
The question is no longer whether obesity is changing India.
The question is whether your organization is ready to understand what comes next.
Download your complimentary copy of India Obesity Intelligence and start reading India’s obesity signals before your next business, healthcare, or policy decision.
INDIA IS GETTING HEAVIER!
The Intelligence is still Scattered
IF THE QUESTION IS
OBESITY IN INDIA,
THE CONVERSATION BEGINS HERE
INDIA IS
GETTING HEAVIER!
The Intelligence is
still Scattered
IF THE QUESTION IS
OBESITY IN INDIA,
THE CONVERSATION BEGINS HERE
OBESITY IS NOT WAITING
FOR INDIA TO UNDERSTAND IT.
It is already moving.
From adults to teenagers.
From clinics to kitchens.
From weighing scales to blood reports.
From diet charts to drug conversations.
From personal shame to public health.
India cannot solve a fast-moving
problem with slow, scattered understanding.
KOBI maps the real decision
ecosystem behind obesity in India.
That is why KOBI exists.
India recognises obesity.
But hasn’t yet medicalised it.
%
say obesity is very serious.
%
would go to a doctor first.
OBESITY IS NOT WAITING
FOR INDIA TO UNDERSTAND IT.
It is already moving.
From adults to teenagers.
From clinics to kitchens.
From weighing scales to blood reports.
From diet charts to drug conversations.
From personal shame to public health.
India cannot solve a fast-moving problem with slow, scattered understanding.
KOBI maps the real decision ecosystem behind obesity in India.
That is why KOBI exists.
India recognises obesity.
But hasn’t yet medicalised it.
%
say obesity is very serious.
%
would go to a doctor first.
INDIA IS NOT A
COPY-PASTE OBESITY MARKET.
You cannot read India only
through global obesity trends.
In India, weight decisions are shaped by
doctors, families, food habits, pharmacies,
festivals, fitness promises, social media,
price sensitivity, stigma, and silence.
KOBI maps the real decision
ecosystem behind obesity in India.
So global assumptions are not
brought into an Indian reality.
India is shifting
from self-managed
weight loss to
structured care.
%
of fitness/nutrition pros say most clients dont see obesity as medical
%
expect more structured help-seeking in the next year
INDIA IS NOT A
COPY-PASTE OBESITY MARKET.
You cannot read India only
through global obesity trends.
In India, weight decisions are shaped by
doctors, families, food habits, pharmacies,
festivals, fitness promises, social media,
price sensitivity, stigma, and silence.
KOBI maps the real decision
ecosystem behind obesity in India.
So global assumptions are not
brought into an Indian reality.
India is shifting
from self-managed
weight loss to
structured care.
%
of fitness/nutrition pros say most clients dont see obesity as medical
%
expect more structured help-seeking in the next year
PLANNING ANYTHING AROUND
OBESITY IN INDIA?
START WITH
Krea Obesity Intelligence
Before you build, launch, research,
communicate, or invest, ask :
Who is the real audience?
What do they believe?
Who do they trust?
What is stopping action?
What will make them move?
The market is interested.
Confidence is the conversion barrier.
%
of GLP-1 aware consumers are exploring or seriously considerting treatment
%
hesitate due to cost and fear
PLANNING ANYTHING AROUND
OBESITY IN INDIA?
START WITH
Krea Obesity Intelligence
Before you build, launch, research,
communicate, or invest, ask :
Who is the real audience?
What do they believe?
Who do they trust?
What is stopping action?
What will make them move?
The market is interested.
Confidence is the conversion barrier.
%
of GLP-1 aware consumers are exploring or seriously considerting treatment
%
hesitate due to cost and fear
Talk to Krea
Talk to Krea before your next India obesity decision. Email: rfq@krea.in
